Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$11.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 20 most recent Form 4 transactions.
| Sep 4 | TRDA | Entrada Therapeutics, Inc. | SSELL | 38,500 | $7.11 | $273.7K | -0.9% | Open the original filing on SEC.gov |
| Sep 3 | TRDA | Entrada Therapeutics, Inc. | SSELL | 32,263 | $7.17 | $231.3K | -0.8% | Open the original filing on SEC.gov |
| Sep 2 | TRDA | Entrada Therapeutics, Inc. | SSELL | 25,131 | $7.19 | $180.7K | -0.6% | Open the original filing on SEC.gov |
| Sep 1 | TRDA | Entrada Therapeutics, Inc. | SSELL | 29,088 | $7.06 | $205.4K | -0.7% | Open the original filing on SEC.gov |
| Aug 31 | TRDA | Entrada Therapeutics, Inc. | SSELL | 44,259 | $6.99 | $309.4K | -1.0% | Open the original filing on SEC.gov |
| Aug 28 | TRDA | Entrada Therapeutics, Inc. | SSELL | 3,733 | $7.01 | $26.2K | <0.1% | Open the original filing on SEC.gov |
| Aug 27 | TRDA | Entrada Therapeutics, Inc. | SSELL | 38,922 | $7.20 | $280.2K | -0.9% | Open the original filing on SEC.gov |
| Aug 26 | TRDA | Entrada Therapeutics, Inc. | SSELL | 14,569 | $7.06 | $102.9K | -0.3% | Open the original filing on SEC.gov |
| Aug 25 | TRDA | Entrada Therapeutics, Inc. | SSELL | 26,522 | $7.54 | $200K | -0.6% | Open the original filing on SEC.gov |
| Aug 24 | TRDA | Entrada Therapeutics, Inc. | SSELL | 21,623 | $7.34 | $158.7K | -0.5% | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV◆ | 6M | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV◆ | 22.5M | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV◆ | 5M | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | PBUY | 1.1M | $18.00 | $20M | +12.2% | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV | 1.6M | — | — | +20.8% | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV | 5.9M | — | — | +357.1% | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV | 1.3M | — | — | +384.6% | Open the original filing on SEC.gov |
| May 13, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL | 630,191 | $8.06 | $5.1M | -23.0% | Open the original filing on SEC.gov |